RPWA
ABMD

Regent Peak Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Regent Peak Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-155
Closed -$50K – 1094
2020
Q4 		$50K Buy
+155
New +$42.9K 0.02% 311

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Regent Peak Wealth Advisors's ABMD Position: Q1 2021 in Review

Regent Peak Wealth Advisors sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 155 shares — an estimated $50K sold.

Regent Peak Wealth Advisors first reported a position in ABMD in Q4 2020 and held it in 1 quarter. The position peaked at $50K in Q4 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Regent Peak Wealth Advisors reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Regent Peak Wealth Advisors sold 155 Abiomed Inc shares in Q1 2021, an estimated $50K.
  • Regent Peak Wealth Advisors first reported a position in Abiomed Inc in Q4 2020 and held it in 1 quarter.
  • Regent Peak Wealth Advisors's Abiomed Inc position peaked at $50K in Q4 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Regent Peak Wealth Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.